• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » psychopharmacology

Articles Tagged with ''psychopharmacology''

shutterstock_2664322029.jpg

How to Start a Psych Medication II

August 11, 2025
Chris Aiken, MD and Kellie Newsome, PMHNP

Meds that require special skill to start: Antipsychotics, Cobenfy, and a research update on antidepressant metabolism in Asians.



Read More
shutterstock_2661541013.jpg

How to Start a Psych Medication

August 4, 2025
Chris Aiken, MD and Kellie Newsome, PMHNP

Before you cook, oil the pan; before you plant that spring lawn, aerate the soil. Before you start a psych med, these are six things you need to have in place.



Read More
WhenItsNotTheMed.jpeg

When a “Miracle” Med Isn’t

August 4, 2025
Daniel Carlat, MD

You start a medication. The patient feels better in two weeks. You think: “Finally. This one works.” But six weeks later, the magic’s gone.


Read More
Clinical Update

Substance Use Disorder Treatment: Medication or Psychotherapy?

July 1, 2025
Noah Capurso, MD, MHS
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Noah Capurso, MD, MHS. Assistant Medical Director, Addiction Services Division, Connecticut Valley Hospital; Associate Clinical Professor of Psychiatry, Yale University; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Capurso has no financial relationships with companies related to this material.

Psychotherapy and medication management are the two cornerstones of addiction treatment, but they are not equally effective across different substance use disorders. This article reviews evidence from both therapeutic approaches and introduces the concept of a treatment spectrum, with medication on one end and therapy on the other. This spectrum can be a useful framework when discussing treatment options with patients and in treatment planning.


Read More
shutterstock_2637648401.jpg

Psychopharm Secrets: Coming Off Meds

June 23, 2025
Chris Aiken, MD and Kellie Newsome, PMHNP
There’s a hidden placebo response to watch for when patients stop meds on their own.

Read More
shutterstock_2639254965.jpg

Psychopharm Secrets: Starting Meds

June 16, 2025
Chris Aiken, MD and Kellie Newsome, PMHNP
We look at a hidden placebo effect that can confuse the picture when starting a medication.
Read More
shutterstock_2550315445.jpg

Psychopharm Secrets: Side Effects

January 13, 2025
Kellie Newsome, PMHNP and Chris Aiken, MD

Depression and cognitive impairment on benzos, tardive dyskinesia, anticholinergics, and neurotoxicity from high dose stimulants. These are the side effects that patients aren’t likely to notice until it’s too late.


Read More
shutterstock_2473199825.jpg

Psychopharm Secrets: What Patients Won’t Tell You

November 4, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.


Read More
Research Update

Antipsychotic Polypharmacy: Maybe Not So Risky After All?

July 1, 2024
Sébastien Hardy, PharmD, BCPS
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Sébastien Hardy, MD. Dr. Hardy has no financial relationships with companies related to this material.

The findings of this large study offer some reassurance about the safety and efficacy of antipsychotic polypharmacy, despite general treatment guidelines cautioning against it.



Read More
Research Update

Does Menopause Increase Risk of Psychosis?

July 1, 2024
Briana Tillman, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Briana Tillman, MD. Dr. Tillman has no financial relationships with companies related to this material.

This comprehensive study highlights the need for gender-specific treatment in schizophrenia spectrum disorders, revealing that hormonal changes call for lower antipsychotic doses for female patients under 45 and higher doses for those who are post-menopausal.


Read More
Previous 1 2 3 4 5 6 7 8 9 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • GFB1e_Spiral.png

    Geriatric Psychiatry Fact Book, First Edition (2025)

    Everything you need to help your older adult patients from the unbiased clinical experts who...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.